ARV-766 (ARV766) is a PROTAC degrader of AR (androgen receptor) with anticancer activity. As a small molecule, androgen receptor (AR)-targeted PROTAC protein degrader, it is being developed by Arvinas for the treatment of prostate cancer.

纯度：≥98%

CAS：2504913-62-4